Monocyte subset distribution in myeloproliferative and myelodysplastic/myeloproliferative neoplasms with monocytosis

Marc Sorigué(Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol), Xavier Calvo(Hospital Del Mar), José‐Tomás Navarro(Universitat Autònoma de Barcelona), Blanca Xicoy(Hospital Universitari Germans Trias i Pujol), Leonor Arenillas(Hospital Del Mar), Marcio Andrade‐Campos(AstraZeneca (United Kingdom)), Lurdes Zamora(Universitat Autònoma de Barcelona), Ana Ferrer(Hospital Del Mar)

Leukemia Research

December 7, 2021

10.1016/j.leukres.2021.106771

Cited by 3

Related Papers

Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia

|New England Journal of Medicine|2022|309

Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia

|Blood|2010|233

Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Espanol de Linfomas/Trasplante de Medula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

|Haematologica|2011|215

Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients

|Blood|2013|189

Human immunodeficiency virus‐associated plasmablastic lymphoma

|Cancer|2012|178